S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
NASDAQ:BTTX

Better Therapeutics SEC Filings & 10K Form

$3.79
-0.28 (-6.88%)
(As of 01/21/2022 04:00 PM ET)
Add
Compare
Today's Range
$3.74
$4.33
50-Day Range
$3.79
$8.73
52-Week Range
$3.74
$29.40
Volume
54,064 shs
Average Volume
76,339 shs
Market Capitalization
$89.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Better Therapeutics (NASDAQ:BTTX) SEC Filings

DateFilerForm TypeView
09/10/2021
4:19 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
09/09/2021
8:30 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
09/09/2021
8:17 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-4/A
08/25/2021
4:29 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
08/24/2021
8:10 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
08/19/2021
8:06 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2021
4:09 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-4/A
08/09/2021
9:44 AM
Feis Lawrence Michael (Filed by)
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form SC 13G
08/06/2021
4:15 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
07/12/2021
8:58 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-4/A
06/25/2021
8:54 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 10-Q/A
06/04/2021
4:06 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
06/04/2021
4:05 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2021
4:25 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2021
4:30 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2021
4:24 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
04/09/2021
5:32 PM
Liu Suying (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2021
5:31 PM
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Mountain Crest Capital LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2021
5:31 PM
Liu Dong (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2021
8:17 AM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/07/2021
8:15 AM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Form 425
03/12/2021
2:31 PM
Mountain Crest Acquisition Corp II (Subject)
Mountain Crest Acquisition Corp II (Subject)
Better Therapeutics (Subject)
Space Summit Capital LLC (Filed by)
Form SC 13G
01/19/2021
4:23 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
4:10 PM
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Mountain Crest Capital LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
4:08 PM
Liu Suying (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
4:07 PM
Liu Dong (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
5:11 AM
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Mountain Crest Capital LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
5:09 AM
Liu Suying (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
5:07 AM
Liu Dong (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2021
4:12 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
10:44 AM
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Zhang Wenhua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
10:41 AM
Milbourn Todd T. (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
10:39 AM
Liu Suying (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
10:37 AM
Haight Nelson (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
10:34 AM
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Mountain Crest Capital LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
10:32 AM
Liu Dong (Reporting)
Mountain Crest Acquisition Corp II (Issuer)
Mountain Crest Acquisition Corp II (Issuer)
Better Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2021
11:15 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form EFFECT
01/07/2021
3:07 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form CERT
01/07/2021
8:37 AM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form 8-A12B
01/04/2021
3:39 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-1/A
12/21/2020
4:23 PM
Mountain Crest Acquisition Corp II (Filer)
Mountain Crest Acquisition Corp II (Filer)
Better Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
This page was last updated on 1/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.